Most recently, Qu et al. [20] (Qu, Zhang et al. 2019) showed that the combination of thioredoxin (Trx), CYFRA21-1, and SCC biomarkers can improve both specificity and sensitivity to diagnose lung cancer patients from healthy subjects. This evidence concerns the gene TXN and lung carcinoma.